Yue Wu

发表

Subsequent malignant neoplasms among children with Hodgkin lymphoma: A report from the Children's Oncology Group.

K. Kelly, L. Constine, D. Friedman, 2020, Blood.

CAR-T cell therapy followed by unrelated cord blood transplantation for the treatment of relapsed/refractory B-cell ALL in children and young adults: superior survival but relatively high posttransplant relapse.

Yuehua Wu, Yue Wu, Zimin Sun, 2021, Transplantation and cellular therapy.

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

C. Bollard, T. Horton, S. Castellino, 2020 .

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.

K. Kelly, D. Hodgson, T. Horton, 2022, The New England journal of medicine.

Neratinib plus capecitabine versus lapatinib plus capecitabine as the third-line therapy for HER2-positive metastatic breast cancer in China: a cost-effectiveness analysis

Yue Wu, Jiangfen Wang, Qingxia Fang, 2022, BMJ Open.

Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies

Yue Wu, Zimin Sun, Zhidan Zhang, 2021, Hematological oncology.

Efficacy of apatinib on multiple advanced-stage nongastric cancers

Wenfeng Li, Y. Zhan, Xueyuan Wu, 2019, Journal of cancer research and therapeutics.

Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study

K. Kelly, D. Hodgson, Inki Lee, 2023, British journal of haematology.

Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting

Yue Wu, Yaxin Cheng, J. Tong, 2021, The Journal of international medical research.

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Steve Y. Cho, K. Kelly, T. Horton, 2022, Journal of Clinical Oncology.

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials.

K. Kelly, S. Bhatia, D. Friedman, 2022, The Lancet. Haematology.

The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer

Jingting Jiang, Yue Wu, Bing Wang, 2023, PloS one.

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

A. Rodday, S. Castellino, Q. Pei, 2023, Journal of Patient-Reported Outcomes.

Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach

Yue Wu, S. Kodad, Waleed Sabry, 2022, Current oncology.